A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis / J. Mascarenhas, H. Kosiorek, J. Prchal, A. Yacoub, D. Berenzon, M.R. Baer, E. Ritchie, R.T. Silver, C. Kessler, E. Winton, M.C. Finazzi, A. Rambaldi, A.M. Vannucchi, D. Leibowitz, D. Rondelli, M.O. Arcasoy, R. Catchatourian, J. Vadakara, V. Rosti, E. Hexner, M. Kremyanskaya, L. Sandy, J. Tripodi, V. Najfeld, N. Farnoud, M.E. Salama, R.S. Weinberg, R. Rampal, J.D. Goldberg, R. Mesa, A.C. Dueck, R. Hoffman. - In: LEUKEMIA. - ISSN 0887-6924. - (2019 Jul 30). [Epub ahead of print] [10.1038/s41375-019-0524-7]
A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis
M.C. Finazzi;A. Rambaldi;
2019
File | Dimensione | Formato | |
---|---|---|---|
s41375-019-0524-7.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
638.51 kB
Formato
Adobe PDF
|
638.51 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.